OCULAR THERAPEUTIX

Oct 05, 2019 · Ocular Therapeutix , Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapies for diseases and conditions of the eye. Its product pipeline include... Ocular Therapeutix , Inc., a biopharmaceutical company, focuses on the formulation, development, and commercialization of therapies for diseases and conditions of the eye using its bioresorbable... Company Profile Ocular Therapeutix , Inc., a biopharmaceutical company, focuses on the formulation, development, and commercialization of therapies for diseases and conditions of the eye using its...

Alimera Sciences

Payment assistance programs are for qualified insured and uninsurred patients who ...

Allergan

Allergan plc (NYSE: AGN), headquartered in Dublin, Ireland, is a global pharmaceutical leader focused on developing, manufacturing and commercializing branded pharmaceutical, device, biologic, surgical and regenerative medicine products for patients around the world. 14 rows · The quantitative allergen -specific IgE test is indicated (1) to determine whether an individual … Description Allergan plc , a pharmaceutical company, develops, manufactures, and commercializes branded pharmaceutical, device, biologic, surgical, and regenerative medicine products worldwide. The...

EyeGate Pharma

Oct 06, 2019 · EyeGate Pharmaceuticals , Inc . is a clinical stage specialty pharmaceutical company , which engages in the development and commercialization of products … About Eyegate Pharmaceuticals Inc Eyegate Pharmaceuticals , Inc. is a clinical-stage specialty pharmaceutical company. The Company is focused on developing … Description EyeGate Pharmaceuticals , Inc., a clinical-stage specialty pharmaceutical company , focuses on developing and commercializing products for treating diseases and disorders of the eye . Its...

Valeant Pharmaceuticals International

Bausch Health (formerly Valeant Pharmaceuticals International ) is Canadas largest publicly traded drugmaker. The multinational specialty pharmaceutical company specializes in developing, manufacturing, and marketing pharmaceuticals and medical devices, with a portfolio of branded prescription, branded generic, and OTC products. See the company profile for 775650 (VRX) including business summary, industry/sector information, number of employees, business summary, corporate governance, key … Valeant Pharmaceuticals International , Inc . (NYSE/TSX: VRX) is a multinational specialty pharmaceutical and medical device company that develops, manufactures and markets a broad range of prescription and non-prescription pharmaceutical products that make a meaningful difference in patients’ lives throughout more than 100 countries.

Envisia Therapeutics

Company profile page for Envisia Therapeutics Inc including stock price, company news, press releases, executives, board members, and contact information. Information on valuation, funding, cap tables, investors, and executives for Envisia Therapeutics . Use the PitchBook Platform to explore the full profile . Envisia Therapeutics operates as a biotechnology company. The Company focuses on unmet medical needs in various areas of ophthalmology. Envisia Therapeutics conducts business in Morrisville, North ...

Clearside Biomedical

Clearside Biomedical , Inc., a late-stage clinical biopharmaceutical company, develops pharmacological therapies to restore and preserve vision for people with serious eye diseases. Oct 03, 2019 · Clearside Biomedical , Inc . is a clinical stage biopharmaceutical company , which engages in the development of drug therapies to treat blinding diseases of the eye. Its pipeline includes... Clearside Biomedical , Inc . (CLSD ), a biopharmaceutical company dedicated to developing and delivering treatments that restore and preserve vision for people with serious back of the eye diseases ...

Graybug Vision

Graybug Vision is developing products to reduce the frequency of dosing for ocular therapies using its injectable controlled release technologies. Our pipeline products cover major eye indications that might lead to blindness, including neovascular (wet) age-related macular degeneration (nAMD), glaucoma, and corneal graft rejection. Graybug Vision Inc Graybug Vision , Inc. operates as a pharmaceutical company. The Company develops drug delivery therapies and sustained-release compounds for the treatment of eye diseases . GrayBug ... Information on valuation, funding, cap tables, investors, and executives for Graybug Vision . Use the PitchBook Platform to explore the full profile .

Graybug Vision

Graybug Vision is developing products to reduce the frequency of dosing for ocular therapies using its injectable controlled release technologies. Our pipeline products cover major eye indications that might lead to blindness, including neovascular (wet) age-related macular degeneration (nAMD), glaucoma, and corneal graft rejection. Graybug Vision Inc Graybug Vision , Inc. operates as a pharmaceutical company. The Company develops drug delivery therapies and sustained-release compounds for the treatment of eye diseases . GrayBug ... Information on valuation, funding, cap tables, investors, and executives for Graybug Vision . Use the PitchBook Platform to explore the full profile .

Taiwan Liposome Compa

Taiwan Liposome Company , Ltd. was founded in 1997 and is headquartered in Taipei City , Taiwan with additional offices in Hsinchu, Hong Kong, Leiden, Melbourne, Shanghai, South San Francisco, and... Taiwan Liposome was founded in 1997. Who are Taiwan Liposome key executives? Taiwan Liposomes key executives are Keelung Hong, George Yeh and Nicole Lin. How many employees does Taiwan Liposome have? Taiwan Liposome has 165 employees. Who are Taiwan Liposome competitors ? Competitors of Taiwan Liposome include Wuhan Healthgen Biotechnology, ApoGen … Description Taiwan Liposome Co Ltd is a Taiwan-based clinical-stage specialty pharmaceutical company. It mainly focuses on the development and commercialization of novel nanomedicines which combines its proprietary lipid-assembled drug delivery platform with approved active pharmaceutical ingredients (APIs).

For More information, Please access Read the total report.